期刊文献+

卵裂期胚胎可溶性人类白细胞抗原G与胚胎种植的关系 被引量:1

The relationship between sHLA-G of cleavage stage embryo andembryo implantation
暂未订购
导出
摘要 目的探讨卵裂期胚胎可溶性人类白细胞抗原G(sHLA-G)与胚胎种植的关系。方法采用酶联免疫吸附实验(ELISA)检测移植后卵裂期胚胎(体外培养2天和3天)培养液中sHLA-G浓度。结果①3天胚胎培养液中sHLA-G表达阳性率为43.3%(26/60),其中妊娠组69.2%(18/26)未妊娠组23.5%(8/34);两者相比,差异有显著性(P<0.001)。②3天胚胎培养液中平均sHLA-G浓度,妊娠组2.16±0.98U/ml,未妊娠组1.50±0.91U/ml;两者相比,差异有显著性(P<0.01)。③平均sHLA-G浓度,2天胚胎为1.53±0.90U/ml,3天胚胎为1.78±0.94U/ml;两者比较,P>0.05,差异无显著性。结论卵裂期胚胎sHLA-G的表达及表达量与胚胎种植有关,可作为妊娠预测指标。 Objective To study the relationship between soluble human leukocyte antigen G (sHLA-G) of cleavage stage embryo and embryo implantation Methods sHLA-G levels in each cleavage stage embryo(d2 and d3)culture medium after transplantation were measured by ELISA method. Results ①The positive rate of sHLA-G expression in d3 embryo culture medium was 43.3% (26/60),that in pregnant group was 69.2% (18/26) ,that in non-pregnant group was 23.5% (8/34).There are significant difference between them. ( P 〈 0.001 ). ②The average sHLA-G levels in d3 embryo culture medium, that in pregnant group was 2.16 ± 0.98 U/m1, and that in non-pregnant group was 1.5 ± 0.91 U/ml. There are significant difference between them( P 〈 0.01 ). ③ The average sI-ILA-G levels that in d2 embryos was1.53 ± 0.90 U/ml,that in d3 embryos was 1.78 ± 0.94 U/ml.There are non-significant difference between them( P 〉 0.05). Conclusion The expression of sHLA-G of cleavage stage embryo is related with the embryo implantation, sHLA-G can be used as a predictor of pregnant.
作者 韩晓敏
机构地区 泰安市中心医院
出处 《中国实验诊断学》 2008年第7期901-903,共3页 Chinese Journal of Laboratory Diagnosis
关键词 胚胎 可溶性人类白细胞抗原G 胚泡种植 embryo sHLA-G embryo implantation
  • 相关文献

参考文献6

  • 1Cao W, Brenner CA, Alikani etal. Search for a human homologue of the mouse Ped gene[J]. Mol Hum Reprod, 1999,5:541-547.
  • 2Jurisicova A, Casper R F, MacLusky N J, et al. HLA-G expression during preimplantation human embryo development [ J]. Prco Natl Acad Sci USA, 1996,93( 1 ) :161.
  • 3Fuzzi B, Rizzo R, Criscuoli L,et al. HLA-G expression in early embryo is a fundamental prerquisite for the obtainment of pregnancy[J]. Eur J Immunol, 2002,32(2) :311.
  • 4Sher G, Keskintepe L, Nouriani M, et al. Expression of sHLA-G in supematants of individually cultured 46-hembryos. A potentially valuable indicator of embryo competency and IVF out come [ J ]. Reprod Biomed Online, 2004,9( 1 ) :74.
  • 5王琼,庄广伦,周灿权,姚书忠,梁晓燕,李洁,徐艳文,方丛.卵裂期胚胎sHLA-G抗原表达及其与胚胎发育和种植的关系[J].中山大学学报(医学科学版),2003,24(5):496-499. 被引量:4
  • 6Menicucci A,Noci I, fuzzi B,et al. Non-classic SHLA-G class 1 in human Oocyte culture medium[J]. Human Immunology, 1999,60(12) : 1054.

二级参考文献6

  • 1Jurisieova A, Casper R F, MaeLusky N J, et al. HLA-G expression during preimplantation human embryo development[J]. Proc Natl Acad Sci U S A, 1996, 93(1):161.
  • 2Chu W, Fant M E, Geraghty D E, et al. Soluble HLA-G in human placentas: synthesis in trophoblasts and interferon-gamma-activated macrophages but not placental fibroblasts[J]. Hum Immunol, 1998, 59(7) :435.
  • 3Rebmann V, Pfeiffer K, Passier M, et al. Detection of soluble HLA-G molecules in plasma and amniotic fluid[J]. Tissue Antigens, 1999, 53(1 ): 14.
  • 4Menicucci A, Noci I, Fuzzi B, et al. Non-classic sHLA class I in human Oocyte culture medium[J]. Human Immunology, 1999, 60(12) : 1054.
  • 5Riteau B, Merrier C, Khalil-Daher I, et al. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition[J]. Int Immunol, 2001, 13(2): 193.
  • 6Fuzzi B, Rizzo R, Criseuoli L, et al. HLA-G expression in early embryo is a fundamental prerequisite for the obtainment of pregnancy[J]. Eur J Immunol, 2002, 32(2):311.

共引文献3

同被引文献58

  • 1Botros L,Sakkas D,Seli E.Metabolomics and its application for non-invasive embryo assessment in IVF.Mol Hum Reprod,2008,14(12):679-90.
  • 2Nel-Themaat L,Nagy ZP.A review of the promises and pitfalls of oocyte and embryo metabolomics.Placenta,2011,32(Suppl3):257-63.
  • 3Aydiner F,Yetkin CE,Seli E.Perspectives on emerging biomarkers for noninvasive assessment of embryo viability in assisted reproduction.Curr Mol Med,2010,10(2):206-15.
  • 4Gardner DK,Wale PL.Analysis of metabolism to select viable human embryos for transfer.Fertil Steril,2013,99(4):1062-72.
  • 5Hardy K,Hooper MA,Handyside AH,et al.Noninvasive measurement of glucose and pyruvate uptake by individual human oocytes and preimplantation embryos.Hum Reprod,1989,4(2):188-91.
  • 6Gott AL,Hardy K,Winston RM,et al.Noninvasive measurement of pyruvate and glucose uptake and lactate production by single human preimplantation embryos.Hum Reprod,1990,5(1):104-8.
  • 7Conaghan J,Hardy K,Handyside AH,et al.Selection criteria for human embryo transfer:a comparison of pyruvate uptake and morphology.J Assist Reprod Genet,1993,10(1):21-30.
  • 8Conaghan J,Handyside AH,Winston RM,et al.Effects of pyruvate and glucose on the development of human preimplantation embryos in vitro.J Reprod Fertil,1993,99(1):87-95.
  • 9Turner K,Martin KL,Woodward BJ,et al.Comparison of pyruvate uptake by embryos derived from conception and non-conception natural cycles.Hum Reprod,1994,9(12):2362-6.
  • 10Gardner DK,Lane M,Stevens J,et al.Noninvasive assessment of human embryo nutrient consumption as a measure of developmental potential.Fertil Steril,2001,76(6):1175-80.

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部